BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31909457)

  • 1. Liver transplantation as an option of treatment for a giant primary hepatic neuroendocrine tumour.
    Oczkowicz G; Caban A; Zemczak A; Kunikowska J; Kos-Kudła B; Król R
    Endokrynol Pol; 2019; 70(6):520-521. PubMed ID: 31909457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic surgery for metastases from neuroendocrine tumors.
    Sarmiento JM; Que FG
    Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
    Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
    Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
    [TBL] [Abstract][Full Text] [Related]  

  • 5.  Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: case report and concise review.
    Gurung A; Yoshida EM; Scudamore CH; Hashim A; Erb SR; Webber DL
    Ann Hepatol; 2012; 11(5):715-20. PubMed ID: 22947536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
    Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
    Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
    Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
    Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with hepatic metastases from neuroendocrine tumors.
    Clift AK; Frilling A
    Ann Saudi Med; 2014; 34(4):279-90. PubMed ID: 25811199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional treatment of gastrointestinal neuroendocrine tumours.
    Ahlman H; Wängberg B; Jansson S; Friman S; Olausson M; Tylén U; Nilsson O
    Digestion; 2000; 62 Suppl 1():59-68. PubMed ID: 10940689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgical management of neuroendocrine tumour hepatic metastases.
    Pathak S; Dash I; Taylor MR; Poston GJ
    Eur J Surg Oncol; 2013 Mar; 39(3):224-8. PubMed ID: 23290582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surgery and transplantation in neuroendocrine tumours.
    Roeyen G; Chapelle T; Borbath I; Delaunoit T; Demetter P; Demolin G; Hendlisz A; Pattyn P; Pauwels S; Peeters M; Van Cutsemo E; Van Hootegem P; Van Laethem JL; Verslype C; Ysebaert D
    Acta Gastroenterol Belg; 2009; 72(1):39-43. PubMed ID: 19402370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic alternative in metastasizing neuroendocrine tumors. In carefully selected cases liver transplantation is possible].
    Oberg K
    Lakartidningen; 1999 Sep; 96(36):3745-7. PubMed ID: 10500387
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
    Dejong CH; Parks RW; Currie E; Piris J; Redhead DN; Garden OJ
    J R Coll Surg Edinb; 2002 Apr; 47(2):495-9. PubMed ID: 12018694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver Metastases.
    Iwasaki M; Tsuchida K; Jinnai H; Komatsubara T; Arisaka T; Tsunemi M; Nakano M; Iijima M; Hiraishi H
    Intern Med; 2017; 56(5):517-522. PubMed ID: 28250297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hepatic neuroendocrine tumour: A rare entity - multimodal approach for diagnosis and management.
    Bari H; Akbar SA; Hanif F
    J Pak Med Assoc; 2021 Jan; 71(1(A)):150-152. PubMed ID: 33484544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare primary hepatic neuroendocrine tumour with laparoscopic resection: a case report.
    Alghamdi HM
    J Med Case Rep; 2023 Jun; 17(1):296. PubMed ID: 37386646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter-based treatments for hepatic metastases from neuroendocrine tumors.
    Kolbeck KJ; Farsad K
    AJR Am J Roentgenol; 2014 Oct; 203(4):717-24. PubMed ID: 25247935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature.
    Blonski WC; Reddy KR; Shaked A; Siegelman E; Metz DC
    World J Gastroenterol; 2005 Dec; 11(48):7676-83. PubMed ID: 16437698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic alternatives in metastatic neuroendocrine tumors.
    Miller CA; Ellison EC
    Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic neuroendocrine metastases: does intervention alter outcomes?
    Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
    J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.